Royce & Associates LP Glaukos Corp Transaction History

Royce & Associates LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$28.78 - $46.83 $723,097 - $1.18 Million	-25,125 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$54.18 - $65.64 $494,392 - $598,965	9,125 Added 57.03%	25,125 $1.37 Million
Q3 2019 Nov 13, 2019	BUY	$58.58 - $83.91 $937,280 - $1.34 Million	16,000 New	16,000 $1 Million

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.73B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.